Introduction
H19 and IGF-2 belong to the family of imprinted genes whose expression depends upon their parental origin. The two genes are located in close physical proximity both in human (11p15.5) and mice (distal chromosome 7) (Zemel et al., 1992) and are reciprocally imprinted. The H19 gene is expressed from the maternally inherited allele and the IGF-2 from the paternally derived allele (Rainier et al., 1993) . The H19 gene is highly expressed in many embryonic tissues but not expressed in neural tissues (Goshen et al., 1993; Lustig et al., 1994) . H19 expression is down regulated postnatally in nearly all tissues.
No protein product is known to be produced by the H19 gene, nevertheless its primary transcript undergoes processing (capping, polyadenylation and splicing like nearly all precursors of mRNAs). It is bound in 28S cytoplasmic RNPs and not to ribosomes (Brannan et al., 1990) . Its function is enigmatic. Genetic analysis of the 11p15.5 region revealed a frequent correlation between the loss of the maternally inherited 11p15.5 region and many cases of Wilm's tumor (Junien, 1992) and some embryonal rhabdomyosarcomas (Scrable et al., 1990) . These correlations and other experimental ®ndings can be explained by assuming the existence of a paternally imprinted (maternally expressed) tumor suppressor gene in this chromosomal area. In order to provide evidence for the proposal that H19 functions as a tumor suppressor gene, Hao et al. (1993) introduced a construct expressing the H19 gene under the control of the metallothionein promoter into cells derived from a kidney tumor. Under conditions of high H19 expression, the cells, which showed prominent morphological changes, grew at a slower rate, had a much lower anchorage independent growth rate in soft agar, and did not develop tumors when injected into nude mice as did cells prior to their transfection with the H19 expression construct. However, recently, ®ndings have been reported, which are contradictory to the proposed tumor suppressor function for the H19 gene. H19, which is not expressed in normal adult tissues, is expressed in several human cancers such as choriocarcinoma and placental site trophoblastic tumor , bladder carcinoma (Cooper et al., 1996; Elkin et al., 1995) , lung cancer (Kondo et al., 1995) , breast adeno-carcinoma (Dugimont et al., 1995) . Cervical carcinoma (Douc-Rasy et al., 1996) and esophageal cancer (Hibi et al., 1996) . Moreover, in tumors formed by the injection of cells of a choriocarcinoma derived cell line, JEG-3, into nude mice, the level of H19 RNA was 3 ± 5 times higher than in the cells before injection (Rachmilewitz et al., 1995) . Also, cells of human bladder carcinoma derived cell lines which do not express H19 (or express it at a very low level) form tumors in nude mice in which H19 RNA can easily be detected (Elkin et al., 1995) .
However, all these observations leaves the question of the role of H19 in tumorigenesis open.
The IGF-2 gene is highly expressed in the embryo and in some fetal tissues. The tissue-speci®c expression pattern of IGF-2 is very similar to that of the H19 gene (Rappolee et al., 1992; Goshen et al., 1993) and, its expression is also postnatally depressed in many adult tissues (Rechler and Nissley, 1990) . Prominent exceptions are the adult liver and the choroid plexus which continue to express IGF-2 at relatively high levels postnatally. It has to be mentioned here that the IFG-2 gene can be transcribed from four dierent promoters, three of which are active during fetal life and in cancer tissues and are imprinted (P2, P3, P4). The fourth (P1)) is not imprinted, and is responsible for IGF-2 expression in the adult liver and in the choroid plexus (Holthuizen et al., 1993; Robertson, 1995; Ekstrom et al., 1995) .
The relationship between the regulation of IGF-2 and H19 is a complex one. It has been proposed that in mice H19 and IGF-2 expression are under the control of a common enhancer, which is *3 kb downstream from the H19 coding region (Sasaki et al., 1992; Ferguson-Smith et al., 1993; Batholomei et al., 1993) . This enhancer, or protein(s), bound to the enhancer region, can activate the H19 promoter on the maternally inherited gene or the IGF-2 promoters on the paternally inherited allele because paternally inherited H19 gene has a more fully methylated promoter which is unable to interact with the H19 downstream enhancer. However, this proposed mechanism can only partly explain the regulation of the H19 and IGF-2 expression. The presence of gene and tissue-speci®c transcription factors is decisive for the actual expression levels of the two genes, and therefore loss of imprinting of either the H19 or the IGF-2 gene is not necessarily accompanied by an increase in the gene's expression. The relationship between H19 and IGF-2 expression in human diers from that in mouse (Adam et al., 1996) . It has been claimed that in the human both genes can be expressed from the same chromosome (Eversole-Cire et al., 1995; Jinno et al., 1995) .
In order to establish more clearly the relationship between the level of H19 and IGF-2 expression and tumorigenicity, we purposely compared the tumorigenic properties of choriocarcinoma cell line derived clones which express H19 and IGF-2 at dierent levels. However, since we were aware that those clones were still heterogeneous in many other properties, we introduced an H19 expressing construct into some of the very low H19-expressing clones and looked for phenotypic dierences related exclusively to the change in H19 expression.
Results
Individual clones were isolated from JAr and JEG-3 original cell cultures. Special care was taken during the cloning procedure in order to ensure that each clone is derived from one cell only.
In Figure 1a we show H19 expression in several of the JEG-3 clones. H19 RNA appears as 2.3 kb band corresponding to the sum of the ®ve exons of the H19 gene (Brannan et al., 1990) . In the majority of the blots done by us and others a second band of approximately 4 kb is visible. The clones C1, C3 and C6 express H19 approximately at the same level as the original culture from which they were derived, but other clones showed very dierent levels of H19 expression, such as clones C2 and C5, in which the H19 level was de®nitely lower and clone C4 which expresses H19 at a signi®cantly higher level. A similar phenomenon was also revealed in clones derived from JAr cell lines (Figure 2 ). (i.e. in JAr-C5 and JAr-C7 high expression, in JAr-C4 low expression). In order to study the relation between H19 and IGF-2 expression, we followed IGF-2 expression in the same JEG-3 and JAr clones. As reported before, no expression of IGF-2 was detected in cells of the original JAr cell line . Similarly in cells of the JAr derived clones IGF-2 expression was not detected. The sole exception was clone JAr-C4 which showed a very low level of expression (data not shown). It is very interesting to note that no consistent correlation was found between the levels of H19 and IGF-2 expression in the dierent JEG-3 clones ( Figure  1b ). For example, high H19 and IGF-2 expression were noted in clone JEG-C1, while high H19 expression and absence of IGF-2 expression was found in clone JEG-C4. In contrast, low H19 and IGF-2 expression were found in clone JEG-C2 and low H19 expression and very high IGF-2 expression was found in clone JEG-C5. These results may indicate that the H19 RNA has no direct in¯uence on the IGF-2 expression level in choriocarcinoma derived cells and IGF-2 expression very likely does not determine the level of the H19 transcript.
Growth rates and anchorage independent growth
High growth rates and anchorage independent growth potential in soft agar of cells are frequently considered as characteristic properties of tumor cells.
As can be seen in Figure 3A there is no obvious correlation between H19 expression and growth rate of the JEG-3 clones. For example JEG-C5 expresses less H19 than JEG-C1 and it is growing faster, but the opposite situation exists between JEG-C2 and JEG-C4 ( Figure 1a ). Also no correlation was obvious between the level of IGF-2 expression and the growth rate of JEG-3 clones. All the JAr clones that express high H19 grew at the same rate as the original culture ( Figure  3B ) but one clone which expresses H19 poorly, JAr-C4, showed a much slower growth rate.
To assess a possible correlation between H19 expression and cell transformation phenotype, the clones were analysed for growth in soft agar. Cells were seeded in parallel in liquid medium culture and in medium containing soft agar. The number of colonies in soft agar was determined and normalized to the frequency of colony formation in liquid medium. The original JAr culture produces larger anchorageindependent colonies and at a much greater frequency than the original JEG-3 cells (Rachmilewitz et al., 1995) . However, all the clones derived from the original JAr and JEG-3 cultures produced anchorageindependent colonies at frequencies similar to that of the original cultures despite greatly dierent levels of H19 expression. The only exception is JAr-C4 which showed a signi®cantly lower anchorage-independent growth than the other JAr clones.
Allelic mode of expression of H19 and IGF-2
In many cases of cancers, including choriocarcinoma (Ariel et al., 1993) and bladder carcinoma (Elkin et al., 1995) biallelic expression of H19 was detected. JAr and JEG-3 cells were analysed for their allelic mode of H19 expression. In order to inquire about the possible relationship between the level and the allelic mode of H19 expression, we studied 14 clones of JAr cells and 13 clones of JEG-3 cells. All the clones showed biallelic expession of H19 (Figure 4a ), notwithstanding that some of the clones expressed H19 at a high level and other clones hardly express H19 at all (Figures 1 and  2 ). The JEG-3 clones were also tested for IGF-2 allelic mode of expression and all of them were found to express it biallelicly ( Figure 4b ). (Zhang and Tycko, 1992) and IGF-2 genes (Tadokoro et al., 1991) . The appearance of the two bands in lanes 2 was absolutely dependent on the RT steps. No products at all appeared on the gels when the RT reaction was omitted, indicating that the RNA preparations used were not contaminated with genomic DNA
Transfection of a non-H19 expressing clone with an H19 expression vector
In order to investigate the possible relationship between the tumorigenic phenotype and the levels of the H19 gene product, we transfected clones that did not express H19 with an expression vector containing the H19 gene under the control of the metallothionein promoter. Transfected and non-transfected cells of the clone JAr-C4 were cultivated in the presence of increasing concentrations of ZnSO 4 ( Figure 5 , lanes 2 ± 9). As can be seen, the zinc ions activated the metallothionein promoter which leads to zinc dependent H19 expression in the transfected cells. The Zn 2+ ion concentration in the culture medium is sucient to activate the metallothionein promoter to some extent (lanes 6 and 7). However in the transfected cells a very signi®cant increase in the H19 RNA level was observed at 50 and 100 mM Zn 2+ ion concentration but no increase in the H19 RNA level could be detected in the original JAr culture (lanes 8 and 9). The same results were obtained with JEG-3 clones C2 and C5 (data not shown). We asked whether any phenotypic change can be related to the H19 expression by comparing the growth rate and anchorage-independent growth in soft agar of JAr-C4, the clone which does not express H19, versus JAr-C4-H19 in the presence of 100 mM Zn 2+ ions, the same clone expressing the H19 gene from the metallothionein promoter. However, neither a dierence in the growth rate nor in the anchorage-independent growth were detected between the two clones.
Tumorogenicity potential of non-H19 and H19 expressing clones in athymic nude mice
The following experiments were performed, in order to further evaluate the possible correlation between tumorigenesis and H19 gene expression. Four H19 expressing clones (JAr-C5, JAr-C7, JEG-C1 and JEG-C4), three H19 low expressing clones (JAr-C4, JEG-C5 and JEG-C2) and their pMEP4-H19 transfectants were injected subcutaneously into athymic nude mice. In order to further stimulate the metallothionein promoter we added 25 mM ZnSO 4 to the mice drinking water. In order to ascertain that the zinc by itself has no eect on the mice and on the tumorogenicity of the clones we injected all the clones and transfectants both to mice with Zn 2+ and without Zn 2+ in their drinking water. No signi®cant dierences were observed in the tumorigenic potentials of the dierent clones and their corresponding transfectants as measured by the time interval between the injection and the time the tumor became visible (16 ± 18 days) and by the weight of the tumor after 25 days. The weight of all the tumors was in the 0.25 ± 0.30 gram range.
Expression of H19 and IGF-2 in subcutaneous tumors in athymic nude mice
We measured the H19 and IGF-2 expression in the cells before and after the tumor formation.
As was shown previously (Rachmilewitz et al., 1995) , 3 ± 5-fold increase in the level of H19 RNA is seen in the tumors derived from JEG-3 cells as compared to the level in the cells of the original culture ( Figure 6, lanes 1 ± 3) . The same phenomenon of increase was also shown in all the tumors derived from JEG-3 clones, especially in the tumors derived from JEG-C5 clone which showed a dramatic increase (Figure 6, lanes 8 and 9) .
We found approximately the same level of H19 RNA in the tumors formed by the dierent JEG-3 clones notwithstanding that the clones in vitro showed a wide range of H19 expression level. H19 RNA level is high in JEG-C4 clone and did not show a signi®cant (Figure 7 , lanes 6 and 7). It was shown that 25 mM of ZnSO 4 in the drinking water can activate the metallothionein promoter in transgenic mice (Palmiter et al., 1983) . However, Zn 2+ did not seem either to in¯uence the growth or the H19 expression level in the tumors that arose from original and transfected cells (Figure 6 , lanes 2 and 3; Figure 7 , lanes 2 and 3).
A very interesting observation was that the IGF-2 gene showed a similar expression pattern as H19 in JEG-3 and JEG-3 clones. Its expression rose in tumors derived from JEG-3 cells of the original cell line and from clones which expressed IGF-2 in low amounts such as the JEG-3 clones C1 and C4 (Figure 8 , lanes 1 ± 6), and no change in its expression level was shown in tumors that arose from JEG-C5 which highly expressed the gene (Figure 8, lanes 7 ± 8) .
Dierent results were observed concerning the expression of IGF-2 in tumors derived from JAr cells as can be seen in Figure 9 , JAr cells and their derived clones do not express IGF-2 (or express it at a very low level; lanes 1, 3, 5 and 7). Also the tumors derived from the cells of the original JAr cell culture did not express IGF-2 (lane 2). Similarly, no expession could be detected in tumors induced by JAr-C7 cells (lane 8). However, in tumors derived from two dierent JAr clones, IGF-2 RNA could be detected; a prominent expression was observed in tumors derived from JAr-C4 (lane 4) and a lower expression was detected in JAr-C5 induced tumors (lane 6).
Discussion
Actually nothing is known about the biological function of the H19 transcript. H19, very likely, acts as an RNA, not only no-H19 protein could be 1 2 3 4 5 6 7 8 9 10 11 12 13 28S - detected but the mouse and human genes do not share an ORF with an amino acid sequence homology. Our knowledge about the H19 RNA does not provide us with any indication as to its possible biological role. Recently it was shown that certain mRNAs may have functions additional to being a template for protein synthesis (Rastinejad et al., 1993) . Whatever its actual function, the H19 gene is highly expressed in embryonal and fetal tissues and in several tumors, but is not or only marginally expressed in normal adult tissues. Therefore, the function of H19, if any, seems to be important in fetal and tumor development. In this work we have tried to de®ne a relationship between the level of H19 and IGF-2 expression and some tumorigenic properties of choriocarcinoma derived cells. However, we could not detect any consistent relationship between the H19 and IGF-2 RNA levels in these cells (which dier greatly among the clones ( Figures  1 and 2) ) and some of their characteristic tumorigenic properties, such as growth rate, anchorage-independent growth in soft agar and their capacity to induce tumors in nude mice (Figure 3 ). This failure may be due to dierent reasons. The ®rst one is simply the possibility that no such relationship exists. The possibility also exists that the experimental conditions did not allow us to detect such a relationship, assuming that it does exist. JAr and JEG-3 cell cultures are very heterogeneous populations, and the clones we isolated from these cell lines may dier each from the other not only in their H19 and IGF-2 expression, but also, simultaneously and independently, in the expression level of other genes. All these variables between the clones may make it dicult to relate any special dierence between the properties of the two clones to dierences in the levels of the H19 and IGF-2 RNAs. Therefore, we transfected clones isolated from the JAr and JEG-3 cell lines with low H19 expression levels with a H19 expression construct under the control of the metallothionein promoter. As a result, we obtained a pair of JAr and a pair of JEG-3 clones, one of each pair expressing H19 at a low level, and the second one expressing H19 at a high level. All the other possible dierences between the cells of such a pair are due, directly or indirectly to the dierent H19 RNA levels, except for unspeci®c eects caused by the presence of the plasmid only. However, no such plasmid eects were detected. But again no signi®cant correlation was found between the level of H19 expression and the tumorigenic properties mentioned above. These ®ndings are however in line with our observations made with the non-transfected clones some with relatively high H19 RNA levels.
18S -
On comparing the levels of H19 RNA in the cells of the tumors to those in the cells grown in culture before their injection, one particular phenomenon drew our attention. Upon injection of cells of those clones with a low H19 RNA level, tumors were formed with a higher H19 RNA level (including cells from the original JEG-3 cell line). However, during tumorigenesis induced by cells of clones which had a relatively high level of H19 RNA there was no increase in the H19 RNA level. Therefore, the H19 RNA level in all the tumors formed was nearly the same, regardless of the H19 RNA level in the cells before their injection into the mice. This phenomenon is completely contradictory to the role of a tumor suppressor gene which has been assigned to the H19 gene.
Does the H19 gene take part in the process of tumorigenesis in cancers such as choriocarcinoma and bladder carcinomas? This question remains an open question. Alternative pathways may transform a cell of a certain cell type, and H19 expression may be on one of those pathways promoting tumorigenesis. The highest levels of the H19 gene product are found in tissues during early development and in several cancers. Till now we cannot distinguish between the possibility that H19 expression promotes carcinogenesis or that its increased expression is a result of the carcinogenic process.
The relationship between the expression levels of the H19 and the IGF-2 genes has been the subject of many investigations. In the mouse either H19 or IGF-2 expression seems to exclude the expression of the second gene from the same allele, and as a result, the expression of the imprinted H19 gene on the maternally inherited chromosome leaves the IGF-2 gene in an inactive state. However, the actual expression level will be determined by the availability of H19 and IGF-2 speci®c transcription factors. The IGF-2/H19 relationship in the human gene seems to be dierent from that in the mouse (Adam et al., 1996) . We did not detect a consistent relationship between the levels of H19 and IGF-2 expression in the JEG-3 clones. Also we failed to detect a correlation between the level of IGF-2 expression and the tumorigenic properties of the cells as mentioned above for the H19 gene.
We measured the IGF-2 mRNA levels in the induced tumors. The level of IGF-2 mRNA in tumors induced by cells of the JEG-3 cell line or by JEG-3 derived clones was higher than in the cells from which they originated. This phenomenon is very similar to that obtained with the H19 gene. However, a somewhat dierent pattern of IGF-2 expression was observed in cells from the JAr cell lines (see Figure 8) . In one of the JAr clones and in the original JAr culture we did not detect an increase in the IGF-2 RNA level as a result of tumor formation. In two other clones we found a substantial increase in the IGF-2 RNA level in the tumors as compared to that in the cells before their injection into the nude mice. These results show that H19 and IGF-2 expression are regulated by dierent pathways, as indicated before. Moreover, one may conclude that IGF-2 is not involved in choriocarcinoma formation.
We found biallelic expression of H19 and IGF-2 in all the clones tested. Biallelic expression of both H19 and IGF-2 was previously observed in testicular germ cell tumors (van Gurp et al., 1994; Verkerk et al., 1997) H19 undergoes loss of imprinting in choriocarcinoma in vivo, therefore the biallelic expression status is preserved in cells derived from choriocarcinoma.
The situation with the IGF-2 gene is somewhat more complicated because the IGF-2 gene has four promoters and one of them, the P1 promoter, which is responsible for IGF-2 expression in the human adult liver and in the choriod plexus is not imprinted. Therefore we cannot be sure if the results described in Figure 4b are due to a loss of imprinting or to promoter switching from an imprinted to the nonimprinted P1 promoter.
In summary we studied two sets of clones, one derived from the choriocarcinoma cell line JAr and the second from the JEG-3 cell line. Notwithstanding the great variance in the level of H19 expression among the clones we did not detect a direct relationship between the level of the H19 in the cells on the one hand and their growth rate, clonogeneity in soft agar and their tumorigeneity on the other hand. An important conclusion can be drawn from our ®ndings in this investigation, the H19 is not a tumor suppressor gene. Other data suggest that a gene other than H19 on the short arm of chromosome 11 might function as a tumor suppressor gene (Koi et al., 1993) which may be the recently identi®ed cyclin-dependent kinase inhibitor p57 kip2 , that causes G1 arrest (Matsuoka et al., 1995) . This gene is paternally imprinted and maternally expressed (Kondo et al., 1996; Hatada et al., 1996; Matsuoka et al., 1996) , but some leakage of the paternal allele has been found. Some lung cancers show selective loss of the maternal allele of this gene, without inactivating mutation of the retained allele (Kondo et al., 1996) . In a number of Wilms' tumors the level of p57 kip2 expression was found to be reduced (Hatada et al., 1996) .
Of special interest is our ®nding that JAr-C4, the only JAr clone with low H19 expression, had a signi®cantly lower growth rate and lower ability to grow in soft agar. These properties did not change after the H19 level in those cells was raised as a result of their transfection with an H19 expressing construct. Moreover, the injection of the JAr-C4 cells into nude mice caused tumor formation as fast as the transfected JAr-C4 cells. Also, the H19 level in those tumors was as high as in all the other tumors. The results with this clone in particular highlights our conclusion that H19 is not a tumor suppressor gene.
H19 is an oncofetal gene, a gene expressed in fetal tissues and in tumors derived from those tissues. However its role, if any, in the process of tumorigenesis remains an enigma.
Materials and methods

Cell culture
The JAr and JEG-3 cell lines, purchased from the American Type Culture Collection, Rockville, USA, were maintained in DMEM-F12 (1 : 1) medium containing 10% fetal calf serum, 25 mM HEPES (pH 7.4), penicillin (180 units/ml), streptomycin (100 mg/ml) and amphotericin B (0.2 mg/ml). 4610 4 cells/cm 2 were plated in polystyrene culture dishes (NUNC). Every 4 days the cells were trypsinized with 0.05% trypsin-EDTA solution (Beit Haemek) for 15 min and replated again at the same initial density.
Cloning of cells
Cells were trypsinized with 0.05% trypsin-EDTA solution for 15 min, vigorously mixed in a vortex, centrifuged and resuspended in the same initial medium. The cells were counted and diluted in serial logarithmic dilutions. Each dilution was plated in 36 wells of 96 well tissue culture dish. Clones were picked from wells in which the probability to ®nd at most one cell was one to ®ve. Clones were expanded and kept frozen.
Isolation of RNA and DNA
Total cellular RNA was isolated from the various tissues by the guanidinium thiocyanate method (McDonald et al., 1987) and from cells according to Chomczynski and Sacchi (1987) . DNA was isolated as described (Ausubel et al., 1993) .
Cell growth assay
3610
4 cells were plated in triplicates in wells of 24 well tissue culture dishes. Cells were assayed at 24 h intervals over a period of 5 days. To assay cell number, the medium was removed, the cells were washed twice with Hank's buered salt solution (HBSS), 0.5 ml of distilled water was added, and the cells were frozen. After thawing, aliquots of the lysate were taken for protein determination by the BioRad protein assay dye reagent.
Anchorage-independence assay
To assess anchorage-independent growth, cells were suspended in soft agar (Difco) according to the procedure described (Freshney, 1990) . Each cell type was tested in duplicate for growth in liquid medium and growth in soft agar. The number of colonies with dense centers was scored for each plate after 2 weeks. The number of colonies in liquid medium allowed correction for viability of the cells of each cell type.
Tumorigenicity assay
Cells were suspended in culture media without serum at approximately 5610 6 cells/ml. Each nude mouse received two subcutaneous injections in the dorsal¯ank region (0.2 ml; 1610 6 cells/site). Cells from each dierent clone were injected into three mice at two sites (six injections of each cell population). The mice were females, CD-1 athymic nude (Nu/Nu) mice, 50 ± 55 days of age. The time the tumors became visible was determined, but tumors continued to grow until the animals were sacri®ced. The wet weights of the tumors were determined immediately after dissection. Portions of the tumors were preserved at 7808C for RNA extraction.
Preparation of H19 transcription vector
800 bp from the human H19 gene 3' region were subcloned at EcoRI site into Bluescript II KS plasmid (Stratagene) behind the T7 and T3 RNA polymerase binding sites. In vitro RNA transcription with T7 RNA polymerase was used to produce antisense H19 cRNA from linearized plasmid DNA. Sense H19 RNA, prepared with T3 polymerase, was used for control. All the described hybridization experiments, using sense H19 RNA failed to produce any signal.
Preparation of probes for Northern blots
32 P-labeled RNA transcripts were produced in vitro using the Amersham Kit and RNA polymerases from Boehringer (Mannheim). Linearized plasmid was prepared by digestion with HindIII for the antisense probe according to the manufacturer's instructions. The fragments were separated from unincorporated nucleotides by ethanolic precipitation.
IGF-2 40 mer oligonucleotide probes were labeled by the 5'-end labeling procedure, using [g-32 P]ATP according to the instructions of the supplier (Oncogene Science).
Northern blotting
5 or 10 mg of each RNA sample was separated by 1% agarose-formaldehyde gel electrophoresis and transferred to Hybond-N Nylon ®lters (Amersham, England). The blots were stained with methylene blue (Sambrook et al., 1989) , in order to ascertain that equal amounts of RNA had been loaded in each lane. The blots were prehybridized at 608C in 50% formamide, 56SSPE, 56Denhardt solution, 0.1% SDS with 0.1 mg/ml herring testes DNA followed by hybridization with speci®c cDNA probes. After hybridization with the IFG-2 oligonucleotide probe the blots were washed in 26SSC; 0.1% SDS and twice in 0.16SSC; 0.1% SDS at 658C and exposed to AGFA Curix ®lm at 7808C (Oncogene Science procedure). Phosphoimaging (Bio-imaging Analyzer, NIH-image 1.58) was used for quantitative analysis of the hybridization signal.
H19 and IGF-2 allelic mode of expression PCR conditions for each of the genes were as follows: 30 or 35 cycles of ampli®cation of H19 was carried out as described by Zhang and Tycko (1992) . 30 ± 40 cycles of ampli®cation of IGF-2 were carried out as described (Tadokoro et al., 1991) . Aliquots were analysed for allelic mode of expression using polymorphic sites detected by RsaI in the H19 gene (Zhang and Tycko, 1992) and by ApaI in the IGF-2 gene (Tadokoro et al., 1991) .
Plasmids pMEP-4H19B which contains the H19 cDNA under the control of the metallothionein promoter was a kind gift from Prof. Benjamin Tycko, Columbia University, New York and described in Hao et al. (1993) .
Transfections
A total of 4610 5 cells in 30 mm dishes were transfected with 14 mg of plasmid using the calcium phosphate precipitation method (Shen et al., 1982) . The precipitates were added to the cells with 1 ml of the usual growth medium. After 16 h of incubation medium was changed to fresh normal medium. In the case of stable transfections, cells were trypsinized and seeded in six well plates, and 24 h later 125 ± 250 ml of Hygromycin (Calbiochem.) was added to the media to initiate selection.
